CHMP5 and COVID-19: Since the spike protein in all the emergency use listing (EUL) vaccines approved by WHO [19] shares a similar/identical structural basis for inducing the above-named antibodies, our analysis suggests the impact of Omicron on current therapeutic antibodies by the Omicron spike mutations may also apply to current COVID-19 vaccines.